183 related articles for article (PubMed ID: 29293881)
41. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
Bruun J; Sveen A; Barros R; Eide PW; Eilertsen I; Kolberg M; Pellinen T; David L; Svindland A; Kallioniemi O; Guren MG; Nesbakken A; Almeida R; Lothe RA
Mol Oncol; 2018 Sep; 12(9):1639-1655. PubMed ID: 29900672
[TBL] [Abstract][Full Text] [Related]
42. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
Al-Badran SS; Grant L; Campo MV; Inthagard J; Pennel K; Quinn J; Konanahalli P; Hayman L; Horgan PG; McMillan DC; Roxburgh CS; Roseweir A; Park JH; Edwards J
J Pathol Clin Res; 2021 Mar; 7(2):121-134. PubMed ID: 33338327
[TBL] [Abstract][Full Text] [Related]
43. Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients.
Lou Y; Yang L; Xu S; Tan L; Bai Y; Wang L; Sun T; Zhou L; Feng L; Lian S; Wu A; Li Z
Discov Oncol; 2024 Jun; 15(1):227. PubMed ID: 38874696
[TBL] [Abstract][Full Text] [Related]
44. Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma.
Zhao Z; Zhang X; Li Z; Gao Y; Guan X; Jiang Z; Liu Z; Yang M; Chen H; Ma X; Yang R; Lu Z; Liu H; Yang L; Wu A; Zou S; Wang X
Am J Cancer Res; 2021; 11(12):6119-6132. PubMed ID: 35018246
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
Shen X; Han J
J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
[TBL] [Abstract][Full Text] [Related]
46. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Kleppe A; Skrede OJ; De Raedt S; Hveem TS; Askautrud HA; Jacobsen JE; Church DN; Nesbakken A; Shepherd NA; Novelli M; Kerr R; Liestøl K; Kerr DJ; Danielsen HE
Lancet Oncol; 2022 Sep; 23(9):1221-1232. PubMed ID: 35964620
[TBL] [Abstract][Full Text] [Related]
47. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
[TBL] [Abstract][Full Text] [Related]
48. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
49. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
51. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
[TBL] [Abstract][Full Text] [Related]
52. Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.
Liu LG; Yan XB; Xie RT; Jin ZM; Yang Y
Med Sci Monit; 2017 Jun; 23():2897-2905. PubMed ID: 28611349
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
[No Abstract] [Full Text] [Related]
54. RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas.
Deb S; Xu H; Tuynman J; George J; Yan Y; Li J; Ward RL; Mortensen N; Hawkins NJ; McKay MJ; Ramsay RG; Fox SB
Br J Cancer; 2014 Mar; 110(6):1606-13. PubMed ID: 24548858
[TBL] [Abstract][Full Text] [Related]
55. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
56. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
Michel P; Paresy M; Lepessot F; Hellot MF; Paillot B; Scotte M; Peillon C; Ducrotté P; Hemet J
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):275-80. PubMed ID: 10750646
[TBL] [Abstract][Full Text] [Related]
57. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
58. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
Søreide K; Søreide JA; Kørner H
World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
[TBL] [Abstract][Full Text] [Related]
59. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
60. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
